Niosomes: A review on niosomal research in the last decade
暂无分享,去创建一个
Purnima Tripathi | Rishikesh Gupta | P. Bhardwaj | Sonia Pandey | S. Pandey | R. Gupta | P. Bhardwaj | Purnima Tripathi
[1] S. Sahoo,et al. Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. , 2011, Molecular pharmaceutics.
[2] F. Rinaldi,et al. Niosomes from 80s to present: the state of the art. , 2014, Advances in colloid and interface science.
[3] N. Chauhan,et al. Curcumin Nanoformulation for Cervical Cancer Treatment , 2016, Scientific Reports.
[4] S. Khoee,et al. Polymer Systems for Ophthalmic Drug Delivery , 2015 .
[5] D. Craig,et al. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. , 2000, International journal of pharmaceutics.
[6] Sanyog Jain,et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. , 2005, International journal of pharmaceutics.
[7] Y. Byun,et al. PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[8] N. Yuksel,et al. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. , 2010, Journal of pharmaceutical sciences.
[9] G. Gutiérrez,et al. Preparation of water-in-oil-in-water (W1/O/W2) double emulsions containing trans-resveratrol , 2014 .
[10] J. Natarajan,et al. A review on novel vesicular drug delivery: proniosomes , 2014, Drug delivery.
[11] G. Buckton. Interfacial Phenomena in Drug Delivery and Targeting , 2000 .
[12] M. Carafa,et al. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[13] Raida Al-Kassas,et al. Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. , 2012, International journal of pharmaceutics.
[14] A. Florence,et al. The preparation and properties of niosomes—non‐ionic surfactant vesicles , 1985, The Journal of pharmacy and pharmacology.
[15] J. Manosroi,et al. Novel Elastic Nanovesicles for Cosmeceutical and Pharmaceutical Applications , 2009 .
[16] C. Moonen,et al. Gene expression and gene therapy imaging , 2007, European Radiology.
[17] Sanyog Jain,et al. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. , 2005, International journal of pharmaceutics.
[18] V. Sankar,et al. Formulation and Optimization of Zidovudine Niosomes , 2010, AAPS PharmSciTech.
[19] S. Bhaskaran,et al. Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. , 2007, Indian journal of dermatology, venereology and leprology.
[20] G. P. Kumar,et al. Nonionic surfactant vesicular systems for effective drug delivery—an overview , 2011 .
[21] A. Masotti,et al. Polyethylenimine bioconjugates for imaging and DNA delivery in vivo. , 2011, Methods in molecular biology.
[22] Leaf Huang,et al. Large scale production of DC-Chol cationic liposomes by microfluidization , 1996 .
[23] M. Saraiva,et al. Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis , 2016, Scientific Reports.
[24] A. Shnyra,et al. Autoimmune Mechanisms of Psoriasis: Pathogenic Role of the IL-23/IL-17 Axis , 2018 .
[25] A. Häkkinen,et al. The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(I)lactide , 2002, AAPS PharmSciTech.
[26] G. Fabbrocini,et al. Nanocarriers for topical administration of resveratrol: a comparative study. , 2013, International journal of pharmaceutics.
[27] D. Greenblatt,et al. Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line. , 2001, Journal of pharmaceutical sciences.
[28] Shivani Verma,et al. Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy , 2018, Asian journal of pharmaceutical sciences.
[29] Masuda,et al. In vitro and in vivo evaluation of ellagic acid on melanogenesis inhibition , 2000, International journal of cosmetic science.
[30] Ling Li,et al. Curcumin-Encapsulated Polymeric Micelles Suppress the Development of Colon Cancer In Vitro and In Vivo , 2015, Scientific Reports.
[31] H. Junginger,et al. Preparation and Characterization of Nonionic Surfactant Vesicles , 1996 .
[32] L. Illum. Is nose‐to‐brain transport of drugs in man a reality? , 2004, The Journal of pharmacy and pharmacology.
[33] F. Iemma,et al. A new crown ether as vesicular carrier for 5-fluoruracil: synthesis, characterization and drug delivery evaluation. , 2007, Colloids and surfaces. B, Biointerfaces.
[34] B. P. Srinivasan,et al. Niosomes as vesicular carriers for delivery of proteins and biologicals , 2011 .
[35] J. Sullivan,et al. Treatments for severe psoriasis , 2009 .
[36] N. K. Jain,et al. Niosomes As Drug Carriers , 1996 .
[37] P. Prabhakara,et al. Development and Characterization of Non-Ionic Surfactant Vesicles(Niosomes) for Oral delivery of Lornoxicam , 2012 .
[38] Lirong Teng,et al. Development of a novel niosomal system for oral delivery of Ginkgo biloba extract , 2013, International journal of nanomedicine.
[39] Javad Zavar Reza,et al. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy , 2018, Journal of Nanobiotechnology.
[40] J. Kreuter,et al. Colloidal Drug Delivery Systems , 1994 .
[41] Sung Hoon Kim,et al. Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-alpha. , 2004, International Immunopharmacology.
[42] B. Lentz,et al. Membrane “fluidity” as detected by diphenylhexatriene probes , 1989 .
[43] O. Sammour,et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. , 2008, International journal of pharmaceutics.
[44] Sanghwa Han. Structure of Ascorbyl Palmitate Bilayers (Aspasomes) from Molecular Dynamics Simulation , 2018 .
[45] J. Manosroi,et al. Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid. , 2008, International journal of pharmaceutics.
[46] C. Charcosset,et al. Liposome preparation using a hollow fiber membrane contactor--application to spironolactone encapsulation. , 2011, International journal of pharmaceutics.
[47] R. Mujoriya,et al. Niosomal Drug Delivery System: The Magic Bullet , 2011 .
[48] H. Junginger,et al. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. , 1999, Biochimica et biophysica acta.
[49] Chen Li,et al. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer , 2016, Scientific Reports.
[50] M. Jufri,et al. Formulation of niosomal gel containing green tea extract (Camellia sinensis L. Kuntze) using thin-layer hydration , 2017 .
[51] A. Mamelak,et al. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601) , 2007, Expert opinion on drug delivery.
[52] T. Maekawa,et al. Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy , 2018, RSC advances.
[53] J. Manosroi,et al. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. , 2008, International journal of pharmaceutics.
[54] A. Elkordy,et al. The Effects of Hydration Parameters and Co-Surfactants on Methylene Blue-Loaded Niosomes Prepared by the Thin Film Hydration Method , 2019, Pharmaceuticals.
[55] J. Manosroi,et al. Transdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatment. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[56] Deqing Sun,et al. Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer , 2016, Tumor Biology.
[57] Sandeep Kumar,et al. NIOSOMES: PRESENT SCENARIO AND FUTURE ASPECTS , 2018, Journal of Drug Delivery and Therapeutics.
[58] Y. Perrie,et al. Characterization and optimization of bilosomes for oral vaccine delivery , 2013, Journal of drug targeting.
[59] A. Saini,et al. NIOSOMES: A NOVEL DRUG DELIVERY SYSTEM , 2011 .
[60] R Hori,et al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. , 1992, The Journal of biological chemistry.
[61] Ahmed Abdelbary,et al. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. , 2015, International journal of pharmaceutics.
[62] A. Florence,et al. Some properties of extruded non-ionic surfactant micro-tubes. , 2003, International journal of pharmaceutics.
[63] R. Cuomo,et al. S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease , 2015, BioMed research international.
[64] A. Luciani,et al. Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. , 2004, Radiology.
[65] N. Venkatesh,et al. Smart niosomes of temozolomide for enhancement of brain targeting , 2018, Nanobiomedicine.
[66] D. Rhodes,et al. Proniosomes: a novel drug carrier preparation. , 1999, International journal of pharmaceutics.
[67] A. Radhi. BENAZEPRIL HYDROCHLORIDE LOADED NIOSOMAL FORMULATION FOR ORAL DELIVERY: FORMULATION AND CHARACTERIZATION , 2018, International Journal of Applied Pharmaceutics.
[68] Wyatt N Vreeland,et al. Controlled self-assembly of monodisperse niosomes by microfluidic hydrodynamic focusing. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[69] Karim Masud Kazi,et al. Niosome: A future of targeted drug delivery systems , 2010, Journal of advanced pharmaceutical technology & research.
[70] Pratyawadee Singhsa,et al. Influence of chemical penetration enhancers on skin permeability of ellagic acid-loaded niosomes , 2013 .
[71] Saeid Moghassemi,et al. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[72] L. T. McGrath,et al. Comparison of two fluorescent probes for the measurement of erythrocyte membrane fluidity in renal dialysis patients , 1995, Irish journal of medical science.
[73] F. Rinaldi,et al. Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20. , 2011, Colloids and surfaces. B, Biointerfaces.
[74] F. Sugawara,et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol , 2003 .
[75] A. Hadjizadeh,et al. Formulation and Characterization of Bovine Serum Albumin-Loaded Niosome , 2016, AAPS PharmSciTech.
[76] Xiaofei Zhang,et al. Paeonol-Loaded Ethosomes as Transdermal Delivery Carriers: Design, Preparation and Evaluation , 2018, Molecules.
[77] A. Goepferich,et al. Targeting the Central Nervous System (CNS): A Review of Rabies Virus-Targeting Strategies. , 2017, Molecular pharmaceutics.
[78] D. Mishra,et al. Niosomes: a controlled and novel drug delivery system. , 2011, Biological & pharmaceutical bulletin.
[79] K. Li,et al. Studies on a high encapsulation of colchicine by a niosome system. , 2002, International journal of pharmaceutics.
[80] David J Weber,et al. The evolution of S100B inhibitors for the treatment of malignant melanoma. , 2013, Future medicinal chemistry.
[81] Srinivas Reddy Devireddy,et al. Formulation and evaluation of fluconazole pro-niosomal gel for topical administration , 2014 .
[82] Bhupinder Singh,et al. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. , 2010, Indian journal of dermatology, venereology and leprology.
[83] B. Godin,et al. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[84] I. Sharifi,et al. Antileishmanial activity and immune modulatory effects of benzoxonium chloride and its entrapped forms in niosome on Leishmania tropica , 2019, Journal of Parasitic Diseases.
[85] Huanxiang Liu,et al. Preparation and In vitro Evaluation of Ethosomal Total Alkaloids of Sophora alopecuroides Loaded by a Transmembrane pH-Gradient Method , 2010, AAPS PharmSciTech.
[86] V. Mayen,et al. Potential use of niosomes for encapsulation of nisin and EDTA and their antibacterial activity enhancement , 2011 .
[87] G. Gutiérrez,et al. Formulation of resveratrol entrapped niosomes for topical use. , 2015, Colloids and surfaces. B, Biointerfaces.
[88] G. Maira,et al. Intracerebral Diffusion of Paramagnetic Cationic Liposomes Containing Gd(DTPA)2- Followed by MRI Spectroscopy: Assessment of Patternc Diffusion and Time Steadiness of a Non-Viral Vector Model , 2006, International journal of immunopathology and pharmacology.
[89] V. Junyaprasert,et al. Effect of Charged and Non-ionic Membrane Additives on Physicochemical Properties and Stability of Niosomes , 2008, AAPS PharmSciTech.
[90] Xiuwen Zhu,et al. Anti-proliferative effects of paeonol on human prostate cancer cell lines DU145 and PC-3 , 2016, Journal of Physiology and Biochemistry.
[91] A. Ahad,et al. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. , 2016, Materials science & engineering. C, Materials for biological applications.
[92] A. Schätzlein,et al. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers , 1996 .
[93] R. Weissleder,et al. Molecular imaging of gene therapy for cancer , 2004, Gene Therapy.
[94] G. Fetih,et al. Niosomes as transdermal drug delivery system for celecoxib: in vitro and in vivo studies , 2016, Polymer Bulletin.
[95] Sanyog Jain,et al. Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. , 2004, International journal of pharmaceutics.
[96] Yifeng Pan,et al. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. , 2012, International journal of pharmaceutics.
[97] M. R. Mozafari,et al. Cytotoxicity evaluation of anionic nanoliposomes and nanolipoplexes prepared by the heating method without employing volatile solvents and detergents. , 2007, Die Pharmazie.
[98] M. R. Mozafari,et al. Construction of stable anionic liposome-plasmid particles using the heating method: a preliminary investigation. , 2002, Cellular & molecular biology letters.
[99] Lisbeth Illum,et al. Nanoparticles for direct nose-to-brain delivery of drugs. , 2009, International journal of pharmaceutics.
[100] E. A. Nunan,et al. In Vitro Skin Permeation and Retention of Paromomycin from Liposomes for Topical Treatment of the Cutaneous Leishmaniasis , 2004, Drug development and industrial pharmacy.
[101] G. Gutiérrez,et al. Preparation and characterization of niosomes containing resveratrol , 2013 .
[102] M. Sasidharan,et al. Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: An efficient carrier for cancer multi-drug delivery. , 2015, Materials science & engineering. C, Materials for biological applications.
[103] G. H. Coombs,et al. Non‐ionic surfactant vesicles, niosomes, as a delivery system for the anti‐leishmanial drug, sodium stibogluconate , 1986, The Journal of pharmacy and pharmacology.
[104] Niosomes as candidate bioconjugates for imaging and pH-sensitive drug delivery nanocarriers for rare pediatric tumors , 2013 .
[105] K. Fung,et al. Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[106] E. Uronnachi. Formulation and Evaluation of Niosomes of Benzyl Penicillin , 2013 .
[107] B. Wang,et al. Study on the physicochemical properties and anti‐inflammatory effects of paeonol in rats with TNBS‐induced ulcerative colitis , 2017, International immunopharmacology.
[108] A. Schätzlein,et al. Polyhedral Non‐ionic Surfactant Vesicles , 1997, The Journal of pharmacy and pharmacology.
[109] S. Saha,et al. Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature. , 2014, Biomaterials.
[110] D. Gopinath,et al. Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications. , 2004, International journal of pharmaceutics.
[111] G. Radha,et al. A review on proniosomal drug delivery system for targeted drug action , 2013, Journal of basic and clinical pharmacy.
[112] C. Pazos,et al. Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol , 2013, The Journal of pharmacy and pharmacology.
[113] J. Bouwstra,et al. LARGE DISK-SHAPED STRUCTURES (DISCOMES) IN NONIONIC SURFACTANT VESICLE TO MICELLE TRANSITIONS , 1992 .
[114] A. Madni,et al. Enhancement of Dissolution and Skin Permeability of Pentazocine by Proniosomes and Niosomal Gel , 2018, AAPS PharmSciTech.
[115] Andrea Sbarbati,et al. A novel near-infrared indocyanine dye-polyethylenimine conjugate allows DNA delivery imaging in vivo. , 2008, Bioconjugate chemistry.
[116] J. Kremer,et al. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations. , 2003, Arthritis and rheumatism.
[117] R. Cuomo,et al. S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells. , 2015, Oncology letters.
[118] M. H. Aboul-Einien,et al. Ascorbic acid derivative-loaded modified aspasomes: formulation, in vitro, ex vivo and clinical evaluation for melasma treatment , 2020, Journal of liposome research.
[119] G. Cevc. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. , 1996, Critical reviews in therapeutic drug carrier systems.
[120] G. Caracciolo,et al. Effect of cholesterol on the formation and hydration behavior of solid-supported niosomal membranes. , 2010, Langmuir.
[121] J. Manosroi,et al. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. , 2010, International journal of pharmaceutics.
[122] B. Wang,et al. Beneficial anti-inflammatory effect of paeonol self-microemulsion-loaded colon-specific capsules on experimental ulcerative colitis rats , 2018, Artificial cells, nanomedicine, and biotechnology.
[123] I. I. Abu Hashim,et al. Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study , 2018, International journal of nanomedicine.
[124] D. Aggarwal,et al. Vesicular systems in ocular drug delivery: an overview. , 2004, International journal of pharmaceutics.
[125] M. Haider,et al. In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration , 2017, Drug delivery.
[126] I. Sharifi,et al. A Novel Niosomal Combination of Selenium Coupled with Glucantime against Leishmania tropica , 2019, The Korean journal of parasitology.
[127] Alamethicin-lipid interaction studied by energy dispersive X-ray diffraction. , 2009, Colloids and surfaces. B, Biointerfaces.
[128] R. Assi,et al. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials , 2016, International journal of nanomedicine.
[129] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .
[130] M. R. Kumar,et al. Analytical methods for assay of ellagic acid and its solubility studies. , 2006, Journal of pharmaceutical and biomedical analysis.
[131] David Heber,et al. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[132] R. Alany,et al. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations , 2014, Drug delivery.
[133] Ijeoma F. Uchegbu,et al. Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .
[134] H. Junginger,et al. Niosomes for oral delivery of peptide drugs , 1992 .
[135] J. Cummings,et al. The Distribution of Doxorubicin in Mice Following Administration in Niosomes , 1988, The Journal of pharmacy and pharmacology.
[136] S. Naderinezhad,et al. Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers , 2017 .
[137] M. Bally,et al. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. , 1985, Biochimica et biophysica acta.
[138] S. Chong,et al. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. , 2012, Colloids and surfaces. B, Biointerfaces.
[139] T. Liu,et al. Evaluation of paeonol‐loaded transethosomes as transdermal delivery carriers , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[140] M. Bally,et al. Generation of multilamellar and unilamellar phospholipid vesicles , 1986 .
[141] I. Uchegbu,et al. Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry , 1995 .
[142] Mengyao Qin,et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. , 2016, Colloids and surfaces. B, Biointerfaces.
[143] Praveen Kumar,et al. Formulation of Niosomal Gel for Enhanced Transdermal Lopinavir Delivery and Its Comparative Evaluation with Ethosomal Gel , 2012, AAPS PharmSciTech.
[144] A. Florence,et al. The effect of non‐ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice , 1985, The Journal of pharmacy and pharmacology.
[145] A. Khamesipour,et al. Preparation and evaluation of niosomes containing autoclaved Leishmania major: a preliminary study , 2012, Journal of microencapsulation.
[146] A. D. de Kroon,et al. Ligation Strategies for Targeting Liposomal Nanocarriers , 2014, BioMed research international.
[147] S. Saraf,et al. Niosomal Delivery of Isoniazid -Development and Characterization , 2011 .
[148] H. Abdelkader,et al. Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone , 2014, Journal of liposome research.
[149] Xiangliang Yang,et al. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer , 2014, International journal of nanomedicine.
[150] Pratyawadee Singhsa,et al. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. , 2012, International journal of pharmaceutics.
[151] J. Lambert,et al. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. , 1992, Journal of acquired immune deficiency syndromes.
[152] A. Fadda,et al. Nanocarriers for antioxidant resveratrol: formulation approach, vesicle self-assembly and stability evaluation. , 2013, Colloids and surfaces. B, Biointerfaces.
[153] I. Sarkar,et al. Photophysical behavior of a new cholesterol attached coumarin derivative and fluorescence spectroscopic studies on its interaction with bile salt systems and lipid bilayer membranes. , 2014, Physical chemistry chemical physics : PCCP.
[154] D. Sharma,et al. Niosomes as Novel Drug Delivery System: Review Article , 2018 .
[155] M. Carafa,et al. Non-phospholipid vesicles for pulmonary glucocorticoid delivery. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[156] L. Casettari,et al. Chitosan in nasal delivery systems for therapeutic drugs. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[157] J. Brewer,et al. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. , 1992, Immunology.
[158] M. Carafa,et al. Designing novel pH-sensitive non-phospholipid vesicle: characterization and cell interaction. , 2006, European Journal of Pharmaceutical Sciences.
[159] P. Pawar,et al. Recent Trends in Niosome as Vesicular Drug Delivery System , 2012 .
[160] R. Alany,et al. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. , 2011, Journal of pharmaceutical sciences.
[161] Min-yan Wei,et al. Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery , 2019, Pharmaceutics.
[162] Huixia Lv,et al. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. , 2013, International journal of pharmaceutics.
[163] D. Passeri,et al. Chitosan Glutamate-Coated Niosomes: A Proposal for Nose-to-Brain Delivery , 2018, Pharmaceutics.
[164] D. Peng,et al. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid , 2013, Drug delivery.
[165] R. Guo,et al. Investigation of PEG 6000/Tween 80/Span 80/H2O niosome microstructure , 2007 .
[166] H. Danafar,et al. Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier , 2018, Advances in pharmacological sciences.
[167] F. Martin. Pharmaceutical manufacturing of liposomes , 1990 .
[168] S. Harikumar,et al. Design and development of cefdinir niosomes for oral delivery , 2013, Journal of pharmacy & bioallied sciences.
[169] M. Carafa,et al. Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. , 2002, International journal of pharmaceutics.
[170] T. Pincus,et al. Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities , 2004, Annals of the rheumatic diseases.
[171] E. Bendas,et al. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. , 2013, International journal of pharmaceutics.
[172] B. Larijani,et al. Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes. , 2015, Materials science & engineering. C, Materials for biological applications.
[173] S. Andò,et al. Transferrin-conjugated pluronic niosomes as a new drug delivery system for anticancer therapy. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[174] F. Iemma,et al. Preparation and characterization of bolaform surfactant vesicles. , 2005, Colloids and surfaces. B, Biointerfaces.
[175] J. Manosroi,et al. Transdermal absorption enhancement of gel containing elastic niosomes loaded with gallic acid from Terminalia chebula galls , 2011, Pharmaceutical biology.